Celldex Therapeutics reported $-20679000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Applied Genetic Technologies AGTC:US $ -17.09M 2.8M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Biocept BIOC:US $ 0.43M 2.26M
Bristol Myers Squibb BMY:US $ 5289M 67M
Celldex Therapeutics CLDX:US $ -20.68M 7.31M
Immunogen IMGN:US $ -37.34M 6.6M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Newlink Genetics NLNK:US $ -7.49M 1.18M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M